Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Immunomodifier Activities of Pseudomonas Exotoxin A
Development of Knowledge About Mental Representations
Pneumocystis Carinii: Metabolism and Host Defenses
Acquisition of Data-Intensive Cyberinfrastructure for Research and Education (DICRE) at North Dakota State University
An Equivalent Circuit Model to Analyze Single-Event Upset in CMOS SRAMs
Recently added grants:
Genetic Factors that Influence Arsenic Toxicity
PCB-mediated dysbiosis of the gut microbiome: A missing link in PCB-mediated neurodevelopmental disorders?
Induction of retinal development by the peripodial epithelium in Drosophila
Blood outer retina barrier regulation
Suprachoroidal nonviral gene transfer of engineered VEGF antagonists
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB67189-3-0-1
Application #
7574874
Study Section
Project Start
2006-09-30
Project End
2009-12-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/ Howard University
$308,392
NIH 2007
N01 HL
Sildenafil for Sickle Cell Disease-Associated Pulmonary Hypertension
Gordeuk, Victor /
$263,550
NIH 2007
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/
Comments
Be the first to comment on this grant